NeOnc prices $15 million registered direct offering of stock and warrants

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) announced on September 9, 2026 that it had entered into definitive securities purchase agreements with new and existing healthcare focused institutional investors for the purchase and sale of 3,571,430 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying warrants to purchase up to 3,571,430 shares at a combined price of $4.20 per share and accompanying warrant in a registered direct offering priced at-the-market under Nasdaq rules.¹

Under the related prospectus supplement, the company is selling 2,610,715 shares of common stock together with 3,571,430 warrants to purchase up to an aggregate of 3,571,430 shares at a combined offering price of $4.20 per share and accompanying warrants.² The company is also offering 960,715 pre-funded warrants to purchasers whose purchase of shares would otherwise result in beneficial ownership above 4.99% (or, at the purchaser's election, 9.99%) of outstanding common stock.² The warrants carry an exercise price of $4.20 per share and will be immediately exercisable following the issuance date and will expire five years from the date of issuance.²

Gross proceeds are estimated at approximately $15 million before deducting placement agent fees and other offering expenses.¹ Roth Capital Partners and A.G.P./Alliance Global Partners are acting as co-placement agents.¹ The offering closes on or about September 10, 2026, subject to customary closing conditions.¹ NeOnc said it expects to use net proceeds for working capital and general corporate purposes and for the redemption of Series A Convertible Preferred Stock.¹

Per the 8-K, the company's Chief Executive Officer and Chief Medical Officer have entered into lock-up agreements restricting sales of common stock for a period of 90 days from the closing date.¹ As of June 30, 2026, NeOnc reported a net loss of $23,059,976 for the six months ended June 30, 2026, and an accumulated deficit of $135,814,631.²